Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
2
33%
Ph phase_3
3
50%
Ph phase_4
1
17%

Phase Distribution

0

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
3(50.0%)
Phase 4Post-market surveillance
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(6)

Detailed Status

Completed6

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (33.3%)
Phase 33 (50.0%)
Phase 41 (16.7%)

Trials by Status

completed6100%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_3

A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients

NCT00037635
completedphase_4

A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer

NCT00037518
completedphase_3

A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis

NCT00042653
completedphase_2

12-month Study of AMG 073 in Renal Osteodystrophy

NCT00527085
completedphase_2

Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)

NCT00110929
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT00037635Phase 3

A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients

Completed
NCT00037518Phase 4

A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer

Completed
NCT00042653Phase 3

A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis

Completed
NCT00527085Phase 2

12-month Study of AMG 073 in Renal Osteodystrophy

Completed
NCT00110929Phase 2

Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)

Completed
NCT00527267Phase 3

Safety and Efficacy Study of AMG 073 in Hemodialysis Subjects

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6